Salveo Capital
Salveo Capital is a venture capital firm based in Northbrook, Illinois, focusing on the burgeoning cannabis industry. The firm brings an institutional quality discipline to evaluating companies, structuring investments, and managing portfolios. Salveo Capital's mission is to reshape the image of legal cannabis and to build a vibrant, sustainable market. It is led by a team experienced in cannabis investment and management, seeking to collaborate closely with entrepreneurs to support their success.
Salveo Capital invests in innovative technologies, products, and services that address the unique requirements of the legalized cannabis sector. Its strategic focus includes cultivation centers, dispensaries, ancillary products, industry support services, software, and technology. The firm actively seeks business opportunities in emerging cannabis markets, establishing brands that emphasize reliability and professionalism.
Some of Salveo Capital's notable investments include businesses involved in cultivation technology, retail dispensary solutions, and industry-specific SaaS platforms. The firm aims to empower entrepreneurs by providing more than just capital, but also strategic guidance and support in the fast-growing cannabis market.
SAM
Sharjah Asset Management (SAM) is a government-owned investment firm based in Sharjah, UAE. Established in 2008 as the investment arm of the Government of Sharjah, it aims to enhance the Emirate's economic competitiveness and growth. Under the leadership of His Highness Sheikh Dr. Sultan bin Muhammad Al Qasimi, SAM is focused on creating sustainable economic development for Sharjah through strategic investments. The team comprises industry professionals dedicated to maximizing returns from investment and asset management activities, committed to innovation and diversification across sectors.
SAM invests across various sectors including financial and commercial services, logistics, technology, real estate, transportation, industrial, and oil and gas. Its investment approach is strategic and diversified, focusing on both local and international opportunities to strengthen Sharjah's economy. The firm plays a crucial role in creating long-term reserves and economic benefits for the region, with technology and innovation driving its investment strategy.
Notable investments in SAM's portfolio demonstrate its broad industry interests. The firm's comprehensive and strategic approach makes it a key player in transforming Sharjah into a globally recognized and economically competitive emirate.
Samaipata
Samaipata is a venture capital firm based in Europe, founded in 2016, with a focus on backing technology entrepreneurs. They are made up of a diverse team committed to empowering visionaries who think differently and dare to better the world. Samaipata positions itself uniquely by not only providing capital but also offering operational support through their Founder Success platform, aiming to drive impactful change with every investment.
The firm invests in tech companies emphasizing on sectors such as AI, SaaS, and marketplace solutions. They typically participate in early-stage rounds, including Seed and Series A, with check sizes ranging from $1-5 million. Samaipata operates primarily in Europe and has established a comprehensive platform that enables them to offer ongoing support to their portfolio companies. With their latest fund, Samaipata III, they are managing €110 million to push forward new technological advancements.
Notable investments include businesses like VIVLA - a real estate tech company, Resident Advisor - a music event platform, and Spotahome - housing rental service. Samaipata leverages its strategic position to identify and partner with high-growth potential companies that are ready to innovate and scale in a rapidly changing market.
Samara Capital
Samara Capital is an Investment firm with a business owner mindset having differentiated investing and operating capabilities.
Our Purpose is to become inspiring business leaders and best in class capital allocators. We pursue superior risk-adjusted returns with our mission to be the most trusted steward of our client’s capital. We derive strength from our culture with key leadership principles and values of Passion for Investing, Customer Obsession, Innovation, Frugality, Business Builder, Growing Talent, Grit, Collaboration and Integrity.
We pride ourselves as one of the most stable and cohesive teams in the industry with a very strong desire and ability to consistently identify, attract and retain the very best of talent at all levels and across industries. We aim to democratize entrepreneurship across Samara Capital group of companies, by attracting, nurturing and rewarding owner mindset professionals having proven track records who are driven individuals with deep desire for accelerated leadership development for themselves and their teams.
Samena Capital
Samena Capital is a principal investment group based in Dubai, focused on the Subcontinent, Asia, Middle East and North Africa regions, collectively referred to as the SAMENA region. The firm is incorporated as an Exempted Company in the Cayman Islands and regulated by the Dubai Financial Services Authority. Through its networks in these regions, Samena Capital integrates its local expertise with global standards to provide both private equity and co-investment strategies in its core geographies.
The company manages assets totaling over $300 million and engages primarily in private equity and co-investments. Samena Capital has raised over $1.3 billion in funds since its inception in 2008 and has returned $1 billion of that capital. The firm's strategy aims for investments within the SAMENA region without specifying industry focus, and its overall assets under management reflect diversified engagements across these regions.
The company's portfolio includes investments across a wide spectrum of industries. Although specific notable investments are not detailed on the site, the firm's historical investment count since 2008 exceeds 60. As such, Samena Capital's influence extends across a diversified range of sectors that support its primary strategies in private equity and co-investments.
Samriddhi Fund
Samriddhi Fund is an impact investment firm based in Mumbai, India, focused on creating positive social impact in low-income states. The firm targets social enterprises that offer solutions in areas such as financial services, healthcare, and clean water access. With a dedicated team working towards sustainable development, Samriddhi Fund aims to empower communities through its investments, supporting jobs creation, and enhancement of access to essential services. Founded with the vision to drive change in underserved regions, it combines financial acumen with a mission-driven approach.
Samriddhi Fund primarily invests in sectors including fintech, healthcare services, and clean technology, with an emphasis on social enterprises in eight low-income states of India. Although specific check sizes are not disclosed, its investment strategy is aligned with fostering measurable social impact. The fund does not explicitly indicate total assets under management or specific partners but focuses on strategic collaborations with social enterprises to amplify its mission.
Notable investments by Samriddhi Fund include Annapurna Finance Pvt. Ltd. for microfinance solutions, Caspian for social impact lending, and ESAF Financial Holdings Pvt. Ltd. for community-based finance. Other significant portfolio companies include INI Farms Pvt. Ltd., promoting organic agriculture, and NatureLand Organic Foods Pvt. Ltd., emphasizing sustainable food production. The firm also invests in technology and green energy through companies like Oriano Clean Energy Pvt. Ltd. and Rite Water Solutions India Pvt. Ltd.
Samruk-Kazyna
Corporate Governance The Corporate Governance system of "Samruk-Kazyna" JSC protects the rights and provides investors with prompt and reliable information about profit, management principles and the state of affairs in the company, minimizes and eliminates possible risks of interests and rights of shareholders.
The Government of the Republic of Kazakhstan is the Sole Shareholder of "Samruk-Kazyna" JSC, empowered to approve the Fund's development strategy, appoint directors and general director, approve financial results and receive dividends; The Board of Directors provides general management of the company and delegates day-to-day operational tasks to the Management Board, which is headed by its CEO.
Joint Stock Company «Samruk-Kazyna» was founded in accordance with the Decree of President of the Republic of Kazakhstan dated October 13, 2008 № 669 «Оn some measures on competitiveness and sustainability of national economy» and by the Decree of the Government of the Republic of Kazakhstan dated October 17, 2008 № 962 «Оn measures on realization of the Decree of President of the Republic of Kazakhstan № 669» by merge of two joint stock companies Kazakhstan Holding for the Management of State Assets SAMRUK and KAZYNA Sustainable Development Fund.
The key area for Samruk-Kazyna and Companies shall be modernization and diversification of national economy in the framework Annual Addresses of the President of Kazakhstan, Strategy of Industrial and Innovation Development of Kazakhstan 2003-2015, “30 Corporate Leaders of Kazakhstan” Program, aims and objectives assigned to Companies and other documents.
Samruk-Kazyna is to provide maximum support to the Government of Kazakhstan, promptly and efficiently responding to the needs in attracting investments into real economy, becoming more active in the regions, strengthening inter-industry and inter-regional links and making maximum use of available advantages and opportunities.
Samsara BioCapital
Samsara BioCapital is a venture capital firm based in the United States that primarily invests in biotechnology companies. The firm focuses on creating transformative therapeutics for patients, emphasizing a deep specialization in the life sciences sector. Headquartered in Palo Alto, Samsara BioCapital was founded by Srinivas Akkaraju, a prominent figure with significant expertise in the field of biotechnology venture investing.
Samsara BioCapital invests in early to late-stage companies within the life sciences field, with a core emphasis on biotechnology. The firm seeks to back companies in North America, providing capital to fuel the development of groundbreaking therapeutics. While specific check sizes are not disclosed, their focus on therapeutics aligns them with major life sciences investment capabilities.
Portfolio highlights include investments in companies such as Acelyrin, Alamar Biosciences, Janux Therapeutics, and Pathalys Pharma. These companies are involved in pioneering work ranging from drug development to innovative biotechnology processes, marking Samsara BioCapital's commitment to reshaping the therapeutic landscape.
Samsung Asset Management
As the leading asset management firm in Korea.
we strive to stay ahead of our peers, aiming to sow
the seeds of tomorrow, with an eye towards growing
into a premier investment manager in Asia.
- Founded in 1988
- Asset Management affiliate of Samsung Group
- No.1 investment manager in Korea by Asset Under Management
Samsung Catalyst Fund
Samsung Catalyst Fund is a multi-stage venture capital fund based in San Jose, operating under the umbrella of Samsung Electronics. It focuses on investing in deep tech AI infrastructure. The fund is fully owned by Samsung Electronics, allowing it to leverage the company's industry leadership and product breadth. The team consists of domain experts who assist startups with shared resources, financing, and corporate development, aimed at fostering mutual growth and benefits.
Samsung Catalyst Fund invests in a broad range of sectors including AI, cloud and data infrastructure, networking and 5G, autonomous systems, sensors, and quantum computing. It operates globally with a focus on enabling life-changing technologies. Though specific fund sizes are not disclosed, the fund structure allows for rapid and transparent investment decisions.
Notable investments include Ada Health, Afero, Anthropic, AvicenaTech, Axelera AI, and Axiado. Ada Health is a digital health company, Afero provides IoT services, Anthropic focuses on AI safety and research, AvicenaTech offers optoelectronics for chip interconnects, and Axelera AI develops AI hardware acceleration technology.